Design and Anticancer Properties of New Water-Soluble Ruthenium-Cyclopentadienyl Complexes

Area of Science:

• Organometallic Chemistry
• Medicinal Chemistry
• Cancer Therapeutics

Background:

• Ruthenium complexes show promise for cancer therapy but often suffer from poor aqueous solubility.
• Improving the solubility of ruthenium complexes is crucial for their clinical application.

Purpose of the Study:

• To synthesize and characterize novel water-soluble ruthenium(II) organometallic complexes.
• To evaluate the antiproliferative potential of these complexes against cancer cell lines.
• To investigate the interaction of a selected complex with human serum albumin.

Main Methods:

• Synthesis and full characterization of eight new Ru(II) complexes using NMR, FT-IR, UV-vis., ESI-HRMS, and cyclic voltammetry.
• Evaluation of antiproliferative activity against MDAMB231, A2780, and HT29 cancer cell lines.
• Fluorescence spectroscopy to study the interaction of a ruthenium complex with human serum albumin (HSA).

Main Results:

• Successful synthesis and characterization of eight water-soluble Ru(II) complexes with diverse ligands.
• Exhibited significant antiproliferative activity, with IC50 values in the micromolar and submicromolar ranges.
• Demonstrated strong quenching of intrinsic albumin fluorescence, indicating interaction with HSA.

Conclusions:

• The synthesized water-soluble ruthenium(II) complexes represent a promising advancement in cancer therapy development.
• These complexes display potent cytotoxic effects against various cancer cell lines.
• Further investigation into their mechanism of action and interaction with biological macromolecules is warranted.